Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BTK | Q06187 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 4/20 | 0.50 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.50 |
| ▸ | RELA | Q04206 | 4/20 | 0.50 |
| ▸ | KDM1A | O60341 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.46 |
| ▸ | CTSK | P43235 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL570801 | 0.92 | GAA (0.54) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL25190566 | 0.89 | BTK (0.61) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL31072098 | 0.87 | BTK (0.49) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL30073691 | 0.86 | BTK (0.50) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL19575961 | 0.85 | BTK (0.43) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL1988919 | 0.82 | NFKB1 (0.54) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL720531 | 0.82 | CTSK (0.50) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL720530 | 0.82 | CTSK (0.50) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL8320677 | 0.82 | CTSK (0.50) | BTKGAANFKB1NFKB2RELA | |
| SCHEMBL13851561 | 0.81 | BTK (0.53) | BTKGAANFKB1NFKB2RELA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4713320-A2 | BCAT2 INHIBITORS | Agios Pharmaceuticals, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024238820-A2 | BCAT2 INHIBITORS | AGIOS PHARMACEUTICALS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |